Katja C. Schmidt’s Post

Further possible mechanisms of action of shock wave therapy: Prof. Lars Wojtecki, Medical Director of the Kempen Teaching Hospital of the University of Düsseldorf, was recently able to demonstrate in a study that Transcranial Pulse Stimulation (TPS) in Alzheimer's disease shows possibly that the shock waves also influence the so-called glymphatic system of the brain, which is responsible for cleansing the brain of waste products, and it was shown that electrical modulations take place through the use of TPS. These findings could reveal further modules of the interaction of the various mechanisms of action that can halt or delay the progression of the disease in many sufferers and significantly improve the quality of life.   The number of patients affected by Alzheimer's disease is increasing dramatically worldwide, so new therapies are urgently needed. The possibilities of TPS as an additive treatment option for Alzheimer's disease are therefore being intensively researched internationally, and interest among experts is growing in line with the expansion of the study situation. This was also evident this weekend at the 1st International TPS Symposium at the Alexius/Josef Hospital in Neuss, where a big number of experts from around the world discussed current research on TPS.   However, the fact that it is also important for those affected, their relatives and society to learn about the latest research findings and thus about new treatment options, especially for methods such as TPS that are already available in clinics and practices, is also linked to an appeal to the media: It is also up to them to report and provide information about innovative ways of treating one of the greatest pandemics of our time.   In addition to other media in TV and print, the BILD newspaper (one of the biggest newspapers in Germany) once again did this yesterday, reporting carefully on Prof. Wojtecki's work on TPS:   https://lnkd.in/dVtxzDp3   #alzheimers #alzheimerstherapy #transcranialpulsestimulation #tps #larswojtecki #tpsstudies #tpsthemediea #bildnewspaper #bildtps #newresearchontps

The neurostimulation procedure Transcranial Pulse Stimulation (TPS) for the treatment of Alzheimer's disease is being intensively studied in clinical trials worldwide. The data is expansive and shows the potential that low-energy shock waves have in the therapy of neurodegenerative diseases such as Alzheimer's – and they can be administered on an outpatient and non-invasive basis.   In Germany, Prof. Ulrich Sprick and his team at the Alexius/Josef Hospital in Neuss/ North Rhine-Westphalia, are playing a leading role in the scientific work on Transcranial Pulse Stimulation (TPS) and in TPS therapy. In the newly founded “Center for Neurostimulation”, the scientists are investigating the innovative therapy method, which is based on targeted stimulation of the central nervous system.   Prof. Sprick and his team are offering a free information event for those affected and their relatives on the possibilities of neurostimulation in people with Alzheimer's dementia. This will take place on Monday, November 18, 2024, starting at 5 p.m. – see an article in the newspaper Rhein-Ruhr:   https://lnkd.in/dfkmCB9v   #transcranialpulsestimulation #tps #neurostimulation #tpsscience #tpsstudies #alzheimers #alzheimerstherapy #profulrichsprick #centerforneurostimulation #alexiusjosefclinic #alzheimersshockwaves #shockwavetherapy  

The neurostimulation procedure Transcranial Pulse Stimulation (TPS) for the treatment of Alzheimer's disease is being intensively studied in clinical trials worldwide. The data is expansive and shows the potential that low-energy shock waves have in the therapy of neurodegenerative diseases such as Alzheimer's – and they can be administered on an outpatient and non-invasive basis.   In Germany, Prof. Ulrich Sprick and his team at the Alexius/Josef Hospital in Neuss/ North Rhine-Westphalia, are playing a leading role in the scientific work on Transcranial Pulse Stimulation (TPS) and in TPS therapy. In the newly founded “Center for Neurostimulation”, the scientists are investigating the innovative therapy method, which is based on targeted stimulation of the central nervous system.   Prof. Sprick and his team are offering a free information event for those affected and their relatives on the possibilities of neurostimulation in people with Alzheimer's dementia. This will take place on Monday, November 18, 2024, starting at 5 p.m. – see an article in the newspaper Rhein-Ruhr:   https://lnkd.in/d8pcGHMw   #transcranialpulsestimulation #tps #neurostimulation #tpsscience #tpsstudies #alzheimers #alzheimerstherapy #profulrichsprick #centerforneurostimulation #alexiusjosefclinic #alzheimersshockwaves #shockwavetherapy  

As we continue to advance in healthcare and research, understanding the mechanisms of healthy aging becomes ever more essential. I recently came across a thought-provoking post by PeterQuick, which sheds light on the latest discussions and findings in this field. Many thanks to Peter for highlighting such an important topic that resonates with all of us invested in the health sciences! Join the discussion in person at the #MEDICA LabMed Forum or watch the Livestream (Link below)

🌌 COSMOS BRAIN 🎆: Visually, the cosmic web with its interlinked galaxies tends to remind us of the nervous system with its interlinked neurons and vice versa. That's why we love what our 🤯 colleagues at the Munich Cluster for Systems Neurology (SyNergy) do... They invite the public to a day full of interesting talks (in German): 🧬 - How does RNA provide instructions for protein production? 🧠 - How can the brain heal itself after an injury 🧠 - Why do muscles tremble in Parkinson's disease? 🧠 - Can Alzheimer's disease be avoided? When: 8. June 10:00 - 15:45 Where: Ludwig-Maximilians-Universität München, Campus Großhadern, Butenandtstr. 13, 81377 #München More info: https://lnkd.in/dkvHMgwH #public #event #brain #research #rna #alzheimers #parkinson #mind #science #talks #outreach #neurons #neuralnetwork #cosmos

We have developed a new method which can be used to estimate the risk of sudden cardiac death! The recent study was published in JACC: Clinical Electrophysiology (https://lnkd.in/dZXvKnqy). The first symptom of an underlying heart disease is often a sudden cardiac death. However, if the risk factors are detected in time, the preventation of the lethal cardiac arrest is often possible. We can estimate the risk factor with any devices measuring heart rate and give a significantly better estimate of the risk than the conventional cardiorespiratory fitness tests! 🫀 🇬🇧 https://lnkd.in/dusnUR3n 🇫🇮 https://lnkd.in/dXj2auPV

🚨 Breakthrough in Heart Failure Treatment: Heart Muscle Regeneration 💖 Researchers at the University of Arizona have made an exciting discovery—artificial hearts can potentially trigger heart muscle regeneration. Published in Circulation, the study shows that these devices allow the heart to "rest," similar to healing after a muscle injury, enabling regeneration in some patients. 🔬 Key Findings: Patients with artificial hearts regenerate muscle cells at 6x the rate of healthy hearts. This reinforces the potential for the heart to regenerate, challenging long-held beliefs. Could lead to revolutionary treatments for 7M+ Americans affected by heart failure.

👐✨ EFSHT Highlights New PhD Research! ✨👐We’re excited to share a groundbreaking PhD thesis on aspects of fine motor performance in neurological disorders affecting hand function. This vital research sheds light on innovative approaches to enhance therapy and improve outcomes for patients with neurological challenges.Join us in celebrating this significant advancement in hand therapy knowledge and practice! 🩺📚Stay connected for more updates on cutting-edge research. 🌟 #EFSHT #HandTherapy #NeurologicalDisorders #PhDResearch

Exciting news! Our remote patient monitoring technology is now supporting the RAPID_REVIVE study, which aims to address the long-term effects of COVID-19. This week, the first patient was enrolled! We're thrilled to be part of this groundbreaking research. Stay tuned for updates! #RAPID_REVIVE #remotepatientmonitoring #COVID19 #healthcareinnovation

📍 Study reveals clearer picture of hypertension’s impact on brain health Excerpt: A Centre for Healthy Brain Ageing (CHeBA) study provides compelling evidence for clinical practice to direct efforts toward preventing white matter damage in individuals with hypertension, to protect against cognitive decline and dementia. High blood pressure has a negative effect on many aspects of health and is also known to affect both the grey and white matter in the brain during the ageing process. Grey matter is where the brain cells exist, whereas white matter constitutes the network of nerve fibres that provides the communication connection between different areas of grey matter.  The study, led by Dr Jing Du and Associate Professor Wei Wen and published March 11, 2024 in Hypertension (https://lnkd.in/ea9ZSXpN), found that compared with grey matter, white matter is more vulnerable to raised blood pressure. Because grey matter has a greater amount of small blood vessels, and therefore a greater supply of blood compared to white matter, we wanted to see if white matter is more susceptible to damage from reduced blood flow caused by high blood pressure, Dr Jing Du. Because grey matter has a greater amount of small blood vessels, and therefore a greater supply of blood compared to white matter, we wanted to see if white matter is more susceptible to damage from reduced blood flow caused by high blood pressure. We applied advanced technology known as the 3D-CNN deep learning model to measure the grey matter and white matter brain ages separately said Dr Jing Du. The researchers looked at brain scans from nearly 40,000 people with varying levels of blood pressure, ranging from normal to high. They found that as blood pressure increased, both grey and white matter showed signs of ageing, with white matter appearing to age faster.  The findings suggest that memory and thinking problems are more likely to occur as a result of high blood pressure’s impact on white matter, rather than grey matter.  The researchers also investigated how different aspects of blood pressure affect brain ageing. They found that systolic blood pressure had a linear relationship with both grey and white matter ageing – meaning as blood pressure increases, so does brain ageing. On the other hand, diastolic blood pressure had a U-shaped relationship, suggesting an optimal range for maintaining brain health. The study suggests that white matter in the brain is particularly vulnerable to high blood pressure. To preserve brain health, it is crucial to keep blood pressure within an optimal range. Managing blood pressure effectively could help protect against cognitive decline and future efforts should focus on monitoring and managing white matter health in people with high blood pressure. Dr Jing Du Read more ➡ https://lnkd.in/eX66tESw #hightbloodpressure #hypertension #brainhealth #dementia #mriscan #neuroimaging #radiology #publichealth #saltintake #diet